431 related articles for article (PubMed ID: 24875882)
1. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
Daugherty MD; Young JM; Kerns JA; Malik HS
PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins.
Delgado-Rodriguez SE; Ryan AP; Daugherty MD
Pathogens; 2023 May; 12(5):. PubMed ID: 37242344
[TBL] [Abstract][Full Text] [Related]
3. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
4. Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis.
Fehr AR; Jankevicius G; Ahel I; Perlman S
Trends Microbiol; 2018 Jul; 26(7):598-610. PubMed ID: 29268982
[TBL] [Abstract][Full Text] [Related]
5. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein.
Karlberg T; Klepsch M; Thorsell AG; Andersson CD; Linusson A; Schüler H
J Biol Chem; 2015 Mar; 290(12):7336-44. PubMed ID: 25635049
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
[TBL] [Abstract][Full Text] [Related]
8. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
Alhammad YMO; Fehr AR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
[TBL] [Abstract][Full Text] [Related]
9. When PARPs Meet Antiviral Innate Immunity.
Zhu H; Zheng C
Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
[TBL] [Abstract][Full Text] [Related]
10. The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation.
Fu W; Yao H; Bütepage M; Zhao Q; Lüscher B; Li J
Drug Discov Today; 2021 Nov; 26(11):2547-2558. PubMed ID: 34023495
[TBL] [Abstract][Full Text] [Related]
11. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
12. The natural history of ADP-ribosyltransferases and the ADP-ribosylation system.
Aravind L; Zhang D; de Souza RF; Anand S; Iyer LM
Curr Top Microbiol Immunol; 2015; 384():3-32. PubMed ID: 25027823
[TBL] [Abstract][Full Text] [Related]
13. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.
Rack JGM; Zorzini V; Zhu Z; Schuller M; Ahel D; Ahel I
Open Biol; 2020 Nov; 10(11):200237. PubMed ID: 33202171
[TBL] [Abstract][Full Text] [Related]
14. The Antiviral Activities of Poly-ADP-Ribose Polymerases.
Malgras M; Garcia M; Jousselin C; Bodet C; Lévêque N
Viruses; 2021 Mar; 13(4):. PubMed ID: 33808354
[TBL] [Abstract][Full Text] [Related]
15. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch NC
Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
[TBL] [Abstract][Full Text] [Related]
16. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
17. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
[TBL] [Abstract][Full Text] [Related]
19. Reversible ADP-ribosylation of RNA.
Munnur D; Bartlett E; Mikolčević P; Kirby IT; Rack JGM; Mikoč A; Cohen MS; Ahel I
Nucleic Acids Res; 2019 Jun; 47(11):5658-5669. PubMed ID: 31216043
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
